Macrophages are key mediators of platelet refractoriness. [PDF]
Pelham-Webb B, Stone EF.
europepmc +1 more source
REFRACTORINESS TO DONOR PLATELETS TRANSFUSION IN PATIENTS WITH APLASTIC ANEMIA AND HEMOBLASTOSIS
Anzhelika F. Rakhmani +6 more
openalex +2 more sources
Demand for human leukocyte antigen or human platelet antigen-selected platelets: An observational study at Canadian Blood Services. [PDF]
Rickards N +5 more
europepmc +1 more source
Incidence and clinical relevance of donor-derived recipient-specific anti-HLA antibodies in haploidentical hematopoietic stem cell transplantation: a retrospective study. [PDF]
Huang X +7 more
europepmc +1 more source
Remimazolam-Based Anesthetic Management in a Patient with Severe Aortic Stenosis and Myelodysplastic Syndrome-Related Thrombocytopenia: A Case Report. [PDF]
Lee SH, Cho SB, Choo H, Park J, Byun SH.
europepmc +1 more source
Genetics by genetic algorithm: Defining an ideal platelet donor population to support patients with HLA-mediated alloimmune refractoriness. [PDF]
Blake JT +4 more
europepmc +1 more source
The evolving landscape of platelet therapy: risks, innovations, and clinical judgment. [PDF]
Mushtaq A +5 more
europepmc +1 more source
European Management of Glanzmann's Thrombasthenia: A Survey of Current Clinical Practice. [PDF]
Fiore M +6 more
europepmc +1 more source

